ALB and metabolic dysfunction-associated steatotic liver disease: After normalization, similar results were found in which IMAT/albumin levels in NAFLD or hepatitis patients were significantly lower than the healthy volunteers (P < 0.001); there were no differences between these two groups of patients (P = 0.70).